超越经典CAR T细胞的CAR细胞:功能性质和应用前景
Elizaveta P Minina1, Dmitry V Dianov1, Saveliy A Sheetikov1
1National Medical Research Centre for Hematology, Ministry of Health of the Russian Federation, Moscow, 125167, Russia.
Biochemistry. Biokhimiia
|June 16, 2024
概括
化学抗原受体 (CARs) 通过工程免疫细胞为癌症治疗提供了一种新的方法. 本综述探讨了T细胞以外的各种免疫细胞中的CARs,检查了潜在的新治疗方法的有效性和安全性.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞工程 细胞工程
- 在瘤学瘤学.
背景情况:
- 化学抗原受体 (CARs) 是工程设计的受体,可引导免疫细胞向特定的抗原.
- 使用与CARs工程的T细胞进行的CAR T细胞疗法,在治疗血液性恶性瘤方面表现有前途.
- 目前的CAR T细胞疗法面临着局限性,这促使人们探索替代性免疫效应细胞.
研究的目的:
- 审查不同类型免疫细胞中CARs的功能特征.
- 评估CAR工程细胞超越T细胞的临床前和临床疗效.
- 评估基于CAR的新型免疫疗法的安全性.
主要方法:
- 对各种免疫细胞中涉及CARs的临床前研究和临床试验的文献综述.
- 分析CAR域结构及其对信号和效应器功能的影响.
- 对不同白细胞类型的CAR细胞疗法的疗效和安全性进行比较评估.
主要成果:
- 可以在各种先天性和适应性免疫细胞中成功表达CARs,增强其细胞毒性潜力.
- 研究表明,在临床前模型中,非T细胞CARs对瘤具有有希望的疗效.
- 最初的临床数据表明,替代CAR细胞疗法的潜在益处和可管理的安全性.
结论:
- 用CARs设计多种免疫细胞提供了一个有希望的策略,以克服CAR T细胞治疗的局限性.
- 对不同免疫细胞类型的CAR功能进行进一步的研究对于开发下一代癌症免疫疗法至关重要.
- 汽车细胞疗法在治疗各种癌症方面具有更广泛的应用潜力,目前正在对安全性和有效性进行调查.
更多相关视频
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
186
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
18.4K
相关概念视频
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cells of the Adaptive Immune Response
979
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
979
T Cell Activation and Clonal Selection
701
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
701
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
